Over-the-counter drugs like acetaminophen (e.g., Tylenol®) can be detrimental. In space, astronauts who have pain and constant discomfort use acetaminophen extensively. Investigators are studying the effects of acetaminophen under space-like conditions since acetaminophen might affect astronauts' health. Investigators also wish to see whether a dietary supplement can reduce some negative effects of acetaminophen. It is believed that acetaminophen promotes the productions of chemicals in the body that could be toxic. In this study, measurements of these chemicals in urine after ingestion of 1 tablet of acetaminophen and compare these measurements to when acetaminophen is taken at the same time as a dietary supplement. This study will also explore whether these products are more abundant when blood is placed under conditions that mimic space. Therefore, this study will collect blood from a few volunteers who took acetaminophen, and acetaminophen with the dietary supplement.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Count the quantity of NAD(P)(H) present with exposure to acetaminophen, with and without NR
Timeframe: At consent and 6 hours post dose
Count the DNA damage occurring upon space-like stressors following exposure to acetaminophen, with and without NR
Timeframe: At consent and 6 hours post dose
Count the quantity of ox-NAD(P) present with exposure to acetaminophen, with and without NR
Timeframe: At consent and 6 hours post dose
Count the quantity of PYR-ribosides present with exposure to acetaminophen, with and without NR
Timeframe: Pre-dose and 6 hour, 12 hour and 24 hour post dose following administration and
Count the quantity of PYR-nucleotides present with exposure to acetaminophen, with and without NR
Timeframe: Pre-dose and 6 hour, 12 hour and 24 hour post dose following administration and